当前位置:首页 >英文主页 >中英对照 > 报告详情

Smartkarma:2023年印度医疗保健-发展与机遇分析报告(英文版)(35页).pdf

上传人: 白**** 编号:136061 2023-08-11 35页 5.54MB

下载:

1、Healthcare in India:Developments andOpportunities to look atResearchReinventedSmartkarma is a globalinvestment research networkthat brings togetherindependent Insight Providers,institutional investors,andcorporate investor relationsprofessionals and management.At Smartkarma,We Do Things DifferentlyW

2、e leverage the online economy,applying this innovative mindset to capitalmarkets.For a single subscription,Smartkarma users can consume all theresearch they need,just like NetIix enables viewers to watch unlimited hoursof content on its platform.At the same time,we address a growing need fora modern

3、 approach to corporate access.In 2019,we launched CorporateSolutions,which allows company executives and investor relations personnelto connect seamlessly to investors and analysts,all within a single network.In this effort,we work closely with global exchanges such as SingaporeExchange,which became

4、 our investor,to provide such services to listedcompanies worldwide.Our model ensures that the research on our platform is objective andunbiased,independent and free from conIicts of interest.The platformdetermines appropriate pricing according to the quality and value of eachresearch piece.This hel

5、ps independent Insight Providers monetise theirresearch and incentivises them to produce truly quality,differentiated workthat stands out from the rest of the market.A commitment to quality is alsowhy we carefully vet and select our Insight Providers.Less than 10 percent ofthe independent analysts w

6、ho apply are approved as Insight Providers onSmartkarma.We currently have over 100 such curated Insight Providerspublishing on the platform,ranging from one-person operations to teams ofmultiple members around the world.In the following pages,you will be able to see for yourself the result of oureff

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要介绍了印度医疗保健行业的发展和机遇,并重点分析了以下五家公司的最新动态: 1. Max Healthcare Institute:KKR & Co Inc计划通过减持Max Healthcare Institute的大部分股份来筹集11.8亿美元。如果行使超额配售选择权,该交易将代表已发行股份的26.83%,并将使KKR的持股比例降至0.71%。 2. HealthCare Global Enterprises (HCG):HCG在过去五年中一直在扩张,但最近开始巩固其地位。HCG的营收和盈利能力正在随着新中心的成熟而增长。HCG预计2023财年将是强劲的一年。 3. Dr.Reddy's Laboratories:印度业务仍然是亮点,但美国业务恢复缓慢。 4. Ajanta Pharma:专注于品牌仿制药,确保了持续增长。 5. Rainbow Children's Hospital:凭借其利基专注和业务恢复,业绩表现强劲。 总体而言,印度医疗保健行业前景广阔,各公司都在积极寻求发展机会,以满足日益增长的医疗需求。
标题长度不得超过10个字。 问题应具有吸引人的特点,能够吸引目标受众。 问题应简洁明了,易于理解。
客服
商务合作
小程序
服务号
折叠